Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.8 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |